Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials (Q33417749)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

26 July 2017

0 references

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials (English)

1 reference

26 July 2017

1 reference

1 reference

B Xiong

1

1 reference

26 July 2017

L Ma

series ordinal

2

1 reference

26 July 2017

Y Cheng

series ordinal

3

1 reference

26 July 2017

C Zhang

series ordinal

4

1 reference

26 July 2017

publication date

25 February 2014

1 reference

European Journal of Surgical Oncology

26 July 2017

published in

1 reference

26 July 2017

volume

40

1 reference

26 July 2017

issue

10

1 reference

26 July 2017

page(s)

1321-1330

1 reference

Chemotherapy for gastric cancer.

26 July 2017

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Neoadjuvant chemotherapy for high-grade advanced gastric cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Clinical cancer research: an embattled species

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Global cancer statistics

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Multidisciplinary management of gastric and gastroesophageal cancers

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Incidence and mortality of gastric cancer in China

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Epidemiology of gastric cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Extended lymph-node dissection for gastric cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Palliative chemotherapy for advanced gastric cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Neoadjuvant chemotherapy versus none for resectable gastric cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Adjuvant and neoadjuvant approaches in gastric cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJSO.2014.01.006

Identifiers

DOI

10.1016/J.EJSO.2014.01.006

1 reference

26 July 2017

1 reference